Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001567619-20-016159

Options or other derivatives

  • Director acquired 28,661 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CAIN CHRISTOPHER W. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-08-27 Grant or award : show line 1 in the form Director Stock Option (Right to Buy) +28,661 28,661 D
Loading xslF345X03/doc1.xml…